Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia 2Neutropenia 1Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1

Interventions

Filgrastim 4Etoposide 3Cytarabine 2Carboplatin 2pegfilgrastim 1liposomal amphotericin B 1Vincristine 1Thrombopoietin 1Thioguanine 1Taxes 1Radiotherapy 1Prednisone 1Peripheral Blood Stem Cell Transplantation 1Paclitaxel 1Moxifloxacin 1Mitoxantrone 1Methotrexate 1Mercaptopurine 1Levofloxacin 1Leucovorin 1Ifosfamide 1Idarubicin 1Granulocyte Colony-Stimulating Factor 1Fluconazole 1Epirubicin 1Doxorubicin 1Docetaxel 1Dexamethasone 1Daunorubicin 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Neutropenia × Amsacrine × Clear all
NCT00002719 2012-07-02

Combination Chemotherapy With or Without G-CSF in Treating Older Patients With Acute Myeloid Leukemia

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Completed
500 enrolled
Other hematologic neoplasm

Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Neutropenia, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡